These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 22253531)

  • 21. De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses.
    Wang D; Schmaljohn AL; Raja NU; Trubey CM; Juompan LY; Luo M; Deitz SB; Yu H; Woraratanadharm J; Holman DH; Moore KM; Swain BM; Pratt WD; Dong JY
    Vaccine; 2006 Apr; 24(15):2975-86. PubMed ID: 16530297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.
    Warfield KL; Swenson DL; Negley DL; Schmaljohn AL; Aman MJ; Bavari S
    Vaccine; 2004 Sep; 22(25-26):3495-502. PubMed ID: 15308377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors.
    Bramble MS; Hoff N; Gilchuk P; Mukadi P; Lu K; Doshi RH; Steffen I; Nicholson BP; Lipson A; Vashist N; Sinai C; Spencer D; Olinger G; Wemakoy EO; Illunga BK; Pettitt J; Logue J; Marchand J; Varughese J; Bennett RS; Jahrling P; Cavet G; Serafini T; Ollmann Saphire E; Vilain E; Muyembe-Tamfum JJ; Hensely LE; Simmons G; Crowe JE; Rimoin AW
    J Infect Dis; 2018 Nov; 218(12):1929-1936. PubMed ID: 30107445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge.
    Grant-Klein RJ; Van Deusen NM; Badger CV; Hannaman D; Dupuy LC; Schmaljohn CS
    Hum Vaccin Immunother; 2012 Nov; 8(11):1703-6. PubMed ID: 22922764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Filovirus infection of STAT-1 knockout mice.
    Raymond J; Bradfute S; Bray M
    J Infect Dis; 2011 Nov; 204 Suppl 3():S986-90. PubMed ID: 21987780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines.
    Marzi A; Kercher L; Marceau J; York A; Callsion J; Gardner DJ; Geisbert TW; Feldmann H
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S404-9. PubMed ID: 26022440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species.
    Zahn R; Gillisen G; Roos A; Koning M; van der Helm E; Spek D; Weijtens M; Grazia Pau M; Radošević K; Weverling GJ; Custers J; Vellinga J; Schuitemaker H; Goudsmit J; Rodríguez A
    PLoS One; 2012; 7(12):e44115. PubMed ID: 23236343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Filoviral immune evasion mechanisms.
    Ramanan P; Shabman RS; Brown CS; Amarasinghe GK; Basler CF; Leung DW
    Viruses; 2011 Sep; 3(9):1634-49. PubMed ID: 21994800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses.
    Natesan M; Jensen SM; Keasey SL; Kamata T; Kuehne AI; Stonier SW; Lutwama JJ; Lobel L; Dye JM; Ulrich RG
    Clin Vaccine Immunol; 2016 Aug; 23(8):717-24. PubMed ID: 27335383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of specific antibody responses to the six species of ebola and Marburg viruses by multiplexed protein microarrays.
    Kamata T; Natesan M; Warfield K; Aman MJ; Ulrich RG
    Clin Vaccine Immunol; 2014 Dec; 21(12):1605-12. PubMed ID: 25230936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.
    Suschak JJ; Schmaljohn CS
    Hum Vaccin Immunother; 2019; 15(10):2359-2377. PubMed ID: 31589088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.
    Kuzmin IV; Schwarz TM; Ilinykh PA; Jordan I; Ksiazek TG; Sachidanandam R; Basler CF; Bukreyev A
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteins.
    Nyakatura EK; Zak SE; Wec AZ; Hofmann D; Shulenin S; Bakken RR; Aman MJ; Chandran K; Dye JM; Lai JR
    J Biol Chem; 2018 Apr; 293(16):6201-6211. PubMed ID: 29500195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.
    Geisbert TW; Feldmann H
    J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1075-81. PubMed ID: 21987744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Bivalent, Spherical Virus-Like Particle Vaccine Enhances Breadth of Immune Responses against Pathogenic Ebola Viruses in Rhesus Macaques.
    Singh K; Marasini B; Chen X; Ding L; Wang JJ; Xiao P; Villinger F; Spearman P
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multivalent DNA Vaccines as A Strategy to Combat Multiple Concurrent Epidemics: Mosquito-Borne and Hemorrhagic Fever Viruses.
    Jiang J; Ramos SJ; Bangalore P; Elwood D; Cashman KA; Kudchodkar SB; Schultheis K; Pugh H; Walters J; Tur J; Yan J; Patel A; Muthumani K; Schmaljohn CS; Weiner DB; Humeau LM; Broderick KE
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33673603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macaque antibodies targeting Marburg virus glycoprotein induced by multivalent immunization.
    Janus BM; Wang R; Cleveland TE; Metcalf MC; Lemmer AC; van Dyk N; Jeong S; Astavans A; Class K; Fuerst TR; Ofek G
    J Virol; 2024 Jul; 98(7):e0015524. PubMed ID: 38832790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse models for filovirus infections.
    Bradfute SB; Warfield KL; Bray M
    Viruses; 2012 Sep; 4(9):1477-508. PubMed ID: 23170168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of Filovirus Glycoprotein-Specific Antibodies.
    Furuyama W; Miyamoto H; Yoshida R; Takada A
    Methods Mol Biol; 2017; 1628():309-320. PubMed ID: 28573631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
    Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
    J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.